-
1
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
RE-LY Steering Committee and Investigators
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
-
2
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
ROCKET AF Investigators
-
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
-
3
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
ARISTOTLE Committees and Investigators
-
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
-
4
-
-
84888362796
-
Edoxaban versus warfarin in patients with atrial fibrillation
-
ENGAGE AF-TIMI 48 Investigators
-
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-2104.
-
(2013)
N Engl J Med
, vol.369
, pp. 2093-2104
-
-
Giugliano, R.P.1
Ruff, C.T.2
Braunwald, E.3
Murphy, S.A.4
Wiviott, S.D.5
Halperin, J.L.6
-
5
-
-
68749089916
-
Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: The Netherlands Stroke Survey
-
Netherlands Stroke Survey Investigators
-
Maasland L, van Oostenbrugge RJ, Franke CF, Scholte Op Reimer WJ, Koudstaal PJ, Dippel DW; Netherlands Stroke Survey Investigators. Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: The Netherlands Stroke Survey. Stroke. 2009;40:2662-2668.
-
(2009)
Stroke
, vol.40
, pp. 2662-2668
-
-
Maasland, L.1
Van Oostenbrugge, R.J.2
Franke, C.F.3
Scholte Op Reimer, W.J.4
Koudstaal, P.J.5
Dippel, D.W.6
-
6
-
-
84888349241
-
Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: Community-based study
-
Fonville AF, Samarasekera N, Hutchison A, Perry D, Roos YB, Al-Shahi Salman R. Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study. Stroke. 2013;44:2729-2734.
-
(2013)
Stroke
, vol.44
, pp. 2729-2734
-
-
Fonville, A.F.1
Samarasekera, N.2
Hutchison, A.3
Perry, D.4
Roos, Y.B.5
Al-Shahi Salman, R.6
-
7
-
-
84878317563
-
Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study
-
Italian Horizon Scanning Project
-
Joppi R, Cinconze E, Mezzalira L, Pase D, Poggiani C, Rossi E, et al; Italian Horizon Scanning Project. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study. Eur J Intern Med. 2013;24:318-323.
-
(2013)
Eur J Intern Med
, vol.24
, pp. 318-323
-
-
Joppi, R.1
Cinconze, E.2
Mezzalira, L.3
Pase, D.4
Poggiani, C.5
Rossi, E.6
-
9
-
-
80052094564
-
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
-
Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58:395-401.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 395-401
-
-
Fang, M.C.1
Go, A.S.2
Chang, Y.3
Borowsky, L.H.4
Pomernacki, N.K.5
Udaltsova, N.6
-
10
-
-
77955872745
-
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
-
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138:1093-1100.
-
(2010)
Chest
, vol.138
, pp. 1093-1100
-
-
Pisters, R.1
Lane, D.A.2
Nieuwlaat, R.3
De Vos, C.B.4
Crijns, H.J.5
Lip, G.Y.6
-
11
-
-
84896117299
-
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of randomised trials
-
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of randomised trials. Lancet. 2014;383:955-962.
-
(2014)
Lancet
, vol.383
, pp. 955-962
-
-
Ruff, C.T.1
Giugliano, R.P.2
Braunwald, E.3
Hoffman, E.B.4
Deenadayalu, N.5
Ezekowitz, M.D.6
-
12
-
-
84868523625
-
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
-
ESC Committee for Practice Guidelines (CPG)
-
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
-
(2012)
Eur Heart J
, vol.33
, pp. 2719-2747
-
-
Camm, A.J.1
Lip, G.Y.2
De Caterina, R.3
Savelieva, I.4
Atar, D.5
Hohnloser, S.H.6
-
13
-
-
84884512133
-
Dabigatran versus warfarin in patients with mechanical heart valves
-
RE-ALIGN Investigators
-
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206-1214.
-
(2013)
N Engl J Med
, vol.369
, pp. 1206-1214
-
-
Eikelboom, J.W.1
Connolly, S.J.2
Brueckmann, M.3
Granger, C.B.4
Kappetein, A.P.5
Mack, M.J.6
-
14
-
-
80155179455
-
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
-
Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. 2011;106:968-977.
-
(2011)
Thromb Haemost
, vol.106
, pp. 968-977
-
-
Gallagher, A.M.1
Setakis, E.2
Plumb, J.M.3
Clemens, A.4
Van Staa, T.P.5
-
15
-
-
79958126202
-
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
-
Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-2372.
-
(2011)
Circulation
, vol.123
, pp. 2363-2372
-
-
Eikelboom, J.W.1
Wallentin, L.2
Connolly, S.J.3
Ezekowitz, M.4
Healey, J.S.5
Oldgren, J.6
-
16
-
-
80054071757
-
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
-
Fox KA, Piccini JP, Wojdyla D, Becker RC, Halperin JL, Nessel CC, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J. 2011;32:2387-2394.
-
(2011)
Eur Heart J
, vol.32
, pp. 2387-2394
-
-
Fox, K.A.1
Piccini, J.P.2
Wojdyla, D.3
Becker, R.C.4
Halperin, J.L.5
Nessel, C.C.6
-
17
-
-
84869100588
-
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: Insights from the ARISTOTLE trial
-
Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012;33:2821-2830.
-
(2012)
Eur Heart J
, vol.33
, pp. 2821-2830
-
-
Hohnloser, S.H.1
Hijazi, Z.2
Thomas, L.3
Alexander, J.H.4
Amerena, J.5
Hanna, M.6
-
18
-
-
84864379749
-
Rivaroxaban vs. Warfarin in Japanese patients with atrial fibrillation-the J-ROCKET AF study
-
J-ROCKET AF Study Investigators
-
Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al; J-ROCKET AF Study Investigators. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation-the J-ROCKET AF study. Circ J. 2012;76:2104-2111.
-
(2012)
Circ J
, vol.76
, pp. 2104-2111
-
-
Hori, M.1
Matsumoto, M.2
Tanahashi, N.3
Momomura, S.4
Uchiyama, S.5
Goto, S.6
|